Gene id |
23532 |
Gene Summary Protein Summary Gene ontology Diseases PubMed |
Gene Summary
|
Gene Symbol |
PRAME Gene UCSC Ensembl |
Aliases |
CT130, MAPE, OIP-4, OIP4 |
Gene name |
PRAME nuclear receptor transcriptional regulator |
Alternate names |
melanoma antigen preferentially expressed in tumors, Opa-interacting protein OIP4, cancer/testis antigen 130, opa-interacting protein 4, preferentially expressed antigen in melanoma, preferentially expressed antigen of melanoma, |
Gene location |
22q11.22 (22559360: 22547695) Exons: 7 NC_000022.11
|
Gene summary(Entrez) |
This gene encodes an antigen that is preferentially expressed in human melanomas and that is recognized by cytolytic T lymphocytes. It is not expressed in normal tissues, except testis. The encoded protein acts as a repressor of retinoic acid receptor, an
|
OMIM |
606021 |
Protein Summary
|
Protein general information
| P78395
Name: Melanoma antigen preferentially expressed in tumors (Opa interacting protein 4) (OIP 4) (Preferentially expressed antigen of melanoma)
Length: 509 Mass: 57890
Tissue specificity: Expressed in testis. Detected in samples of kidney, brain and skin. {ECO
|
Sequence |
MERRRLWGSIQSRYISMSVWTSPRRLVELAGQSLLKDEALAIAALELLPRELFPPLFMAAFDGRHSQTLKAMVQA WPFTCLPLGVLMKGQHLHLETFKAVLDGLDVLLAQEVRPRRWKLQVLDLRKNSHQDFWTVWSGNRASLYSFPEPE AAQPMTKKRKVDGLSTEAEQPFIPVEVLVDLFLKEGACDELFSYLIEKVKRKKNVLRLCCKKLKIFAMPMQDIKM ILKMVQLDSIEDLEVTCTWKLPTLAKFSPYLGQMINLRRLLLSHIHASSYISPEKEEQYIAQFTSQFLSLQCLQA LYVDSLFFLRGRLDQLLRHVMNPLETLSITNCRLSEGDVMHLSQSPSVSQLSVLSLSGVMLTDVSPEPLQALLER ASATLQDLVFDECGITDDQLLALLPSLSHCSQLTTLSFYGNSISISALQSLLQHLIGLSNLTHVLYPVPLESYED IHGTLHLERLAYLHARLRELLCELGRPSMVWLSANPCPHCGDRTFYDPEPILCPCFMPN
|
Structural information |
|
Other Databases |
GeneCards: PRAME  Malacards: PRAME |
|
GO accession | Term name | Evidence code | Go category |
---|
GO:0042974 |
retinoic acid receptor bi nding
|
IBA |
molecular function |
GO:0005737 |
cytoplasm
|
IBA |
cellular component |
GO:0048387 |
negative regulation of re tinoic acid receptor sign aling pathway
|
IDA |
biological process |
GO:0045596 |
negative regulation of ce ll differentiation
|
IDA |
biological process |
GO:0043066 |
negative regulation of ap optotic process
|
IDA |
biological process |
GO:0008284 |
positive regulation of ce ll population proliferati on
|
IDA |
biological process |
GO:0042974 |
retinoic acid receptor bi nding
|
IDA |
molecular function |
GO:0005515 |
protein binding
|
IPI |
molecular function |
GO:0008284 |
positive regulation of ce ll population proliferati on
|
IEA |
biological process |
GO:0043066 |
negative regulation of ap optotic process
|
IEA |
biological process |
GO:0045596 |
negative regulation of ce ll differentiation
|
IEA |
biological process |
GO:0045892 |
negative regulation of tr anscription, DNA-template d
|
IEA |
biological process |
GO:0030154 |
cell differentiation
|
IEA |
biological process |
GO:0005634 |
nucleus
|
IEA |
cellular component |
GO:0040008 |
regulation of growth
|
IEA |
biological process |
GO:0006915 |
apoptotic process
|
IEA |
biological process |
GO:0016020 |
membrane
|
IEA |
cellular component |
GO:0005886 |
plasma membrane
|
IEA |
cellular component |
GO:0005634 |
nucleus
|
IEA |
cellular component |
GO:0005886 |
plasma membrane
|
IEA |
cellular component |
GO:0005654 |
nucleoplasm
|
IDA |
cellular component |
GO:0005886 |
plasma membrane
|
IDA |
cellular component |
GO:0045892 |
negative regulation of tr anscription, DNA-template d
|
IDA |
biological process |
|
|
Associated diseases |
References |
mantle cell lymphoma | PMID:16620968 |
Myelodysplastic syndrome | PMID:24763007 |
Acute promyelocytic leukemia | PMID:18815192 |
Breast cancer | PMID:17624586 |
Melanoma | PMID:27505074 |
Melanoma | PMID:9047241 |
Osteosarcoma | PMID:22390931 |
Ovary adenocarcinoma | PMID:18709641 |
lung adenocarcinoma | PMID:27241212 |
Uveal melanoma | PMID:27486988 |
neuroblastoma | PMID:15240516 |
chronic myeloid leukemia | PMID:20838376 |
Hodgkin's lymphoma | PMID:26044287 |
myeloid leukemia | PMID:16103086 |
megakaryocytic leukemia | PMID:15180862 |
acute myeloid leukemia | PMID:20376794 |
multiple myeloma | PMID:24791872 |
acute lymphocytic leukemia | PMID:27275197 |
Aberrant CpGs in Low Motility Sperm | MIK: 21674046 |
Cryptorchidism | MIK: 28606200 |
Teratozoospermia | MIK: 17327269 |
|
|
PMID |
Condition |
Mutation |
Ethnicity |
Population details |
Infertility_type |
Associated_genes |
Abstract |
17327269 |
Teratozoos permia
|
|
|
13 (5 controls, 8 cases)
|
Male infertility |
GSE6967 analyzed by GEO2R (cutoff 1.5 fold)
|
Show abstract |
21674046 |
Aberrant C pGs in Low Motility Sperm
|
|
|
18
|
Male infertility |
GSE26881
|
Show abstract |
28606200 |
Cryptorchi dism
|
|
|
Monozgotic twin s (1 control, I cwith cryptorc hidism)
|
Male infertility |
MeDIP-Seq
|
Show abstract |
|